PROphylaxis for paTiEnts at risk of COVID-19 infecTion (PROTECT-V)

PROphylaxis for paTiEnts at risk of COVID-19 infecTion (PROTECT-V)

Abstract Background Despite the introduction of vaccination, there remains a need for pre-exposure prophylactic agents against SARS-CoV-2. Several patient groups are more vulnerable to SARS-CoV-2 infection by virtue of underlying health conditions, treatments received or suboptimal responses to vacc...

Full description

Bibliographic Details
Main Authors: Toby J. L. Humphrey, Davinder Dosanjh, Thomas F. Hiemstra, Alex Richter, Michael Chen-Xu, Wendi Qian, Vivekanand Jha, Katrina Gatley, Rakshya Adhikari, Francis Dowling, Rona M. Smith
Format: Article
Language:English
Published: BMC 2023-03-01
Series:Trials
Subjects:
SARS-CoV-2
COVID-19
Prophylaxis
Niclosamide
Ciclesonide
Sotrovimab
Online Access:https://doi.org/10.1186/s13063-023-07128-z

Internet

https://doi.org/10.1186/s13063-023-07128-z

Similar Items